Hemopexin induces neuroprotection in the rat subjected to focal cerebral ischemia

BMC Neuroscience

Volumn 14, Issue , 2013, Pages

  Dong, Beibei ^a   Cai, Min ^a   Fang, Zongping ^a   Wei, Haidong ^a   Zhu, Fangyun ^a   Li, Guochao ^a   Dong, Hailong ^a   Xiong, Lize ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Endogenous protection; Hemopexin; Intracerebroventricular injection; Neuroprotection

Indexed keywords

HEMOPEXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION; WESTERN BLOTTING;

ANIMALS; BRAIN; BRAIN EDEMA; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMOPEXIN; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROGLIA; NEUROLOGIC EXAMINATION; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHOPYRUVATE HYDRATASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS;

EID: 84878718784     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-14-58     Document Type: Article

References (31)

1. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, De Simone G, Ford ES, et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209. 10.1161/CIR.0b013e3182009701, 21160056.
2. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol 2007, 6(5):456-464. 10.1016/S1474-4422(07)70004-2, 17434100.
3. Pillai DR, Dittmar MS, Baldaranov D, Heidemann RM, Henning EC, Schuierer G, Bogdahn U, Schlachetzki F. Cerebral ischemia-reperfusion injury in rats-a 3 T MRI study on biphasic blood-brain barrier opening and the dynamics of edema formation. J Cereb Blood Flow Metab 2009, 29(11):1846-1855. 10.1038/jcbfm.2009.106, 2848453, 19654585.
4. Tang XN, Cairns B, Kim JY, Yenari MA. NADPH oxidase in stroke and cerebrovascular disease. Neurol Res 2012, 34(4):338-345. 3645888, 22643077.
5. Petrov VI, Ponomarev EA, Maskin SS, Strepetov NN. Pharmacological neuroprotection against brain damage in ischemiai/reperfusion experiment. Eksp Klin Farmakol 2011, 74(8):13-16.
6. Muller-Eberhard U. Hemopexin. N Engl J Med 1970, 283(20):1090-1094. 10.1056/NEJM197011122832007, 4921465.
7. Camborieux L, Bertrand N, Swerts JP. Changes in expression and localization of hemopexin and its transcripts in injured nervous system: a comparison of central and peripheral tissues. Neuroscience 1998, 82(4):1039-1052.
8. Kapojos JJ, van den Berg A, Van Goor H, Te LM, Poelstra K, Borghuis T, Bakker WW. Production of hemopexin by TNF-alpha stimulated human mesangial cells. Kidney Int 2003, 63(5):1681-1686. 10.1046/j.1523-1755.2003.00907.x, 12675843.
9. Tolosano E, Fagoonee S, Morello N, Vinchi F, Fiorito V. Heme scavenging and the other facets of hemopexin. Antioxid Redox Signal 2010, 12(2):305-320. 10.1089/ars.2009.2787, 19650691.
10. Li RC, Saleem S, Zhen G, Cao W, Zhuang H, Lee J, Smith A, Altruda F, Tolosano E, Dore S. Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J Cereb Blood Flow Metab 2009, 29(5):953-964. 10.1038/jcbfm.2009.19, 19277051.
11. Yan W, Zhang H, Bai X, Lu Y, Dong H, Xiong L. Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Res 2011, 1402:109-121.
12. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke Stroke 1995, 26(4):627-635.
13. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003, 96(1):233-237.
14. Wang Q, Peng Y, Chen S, Gou X, Hu B, Du J, Lu Y, Xiong L. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia through regulation of endocannabinoid system. Stroke 2009, 40(6):2157-2164. 10.1161/STROKEAHA.108.541490, 19372445.
15. Takahashi N, Takahashi Y, Putnam FW. Complete amino acid sequence of human hemopexin, the heme-binding protein of serum. Proc Natl Acad Sci USA 1985, 82(1):73-77. 10.1073/pnas.82.1.73, 396973, 3855550.
16. Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41(12 Pt 2):1819-1828.
17. Barnard ML, Muller-Eberhard U, Turrens JF. Protective role of hemopexin on heme-dependent lung oxidative stress. Biochem Biophys Res Commun 1993, 192(1):82-87. 10.1006/bbrc.1993.1384, 8476438.
18. Brass CA, Immenschuh S, Song DX, Liem HH, Eberhard UM. Hemopexin decreases spontaneous chemiluminescence of cold preserved liver after reperfusion. Biochem Biophys Res Commun 1998, 248(3):574-577. 10.1006/bbrc.1998.9023, 9703968.
19. Chen CC, Lu YC, Chen YW, Lee WL, Lu CH, Chen YH, Lee YC, Lin ST, Timms JF, Lee YR, et al. Hemopexin is up-regulated in plasma from type 1 diabetes mellitus patients: role of glucose-induced ROS. J Proteomics 2012, 75(12):3760-3777. 10.1016/j.jprot.2012.04.047, 22579751.
20. Dang TN, Bishop GM, Dringen R, Robinson SR. The metabolism and toxicity of hemin in astrocytes. Glia 2011, 59(10):1540-1550. 10.1002/glia.21198, 21681819.
21. Dang TN, Robinson SR, Dringen R. Bishop 2011, Uptake, metabolism and toxicity of hemin in cultured neurons. Neurochem Int: GM.
22. Vincent SH, Grady RW, Shaklai N, Snider JM, Muller-Eberhard U. The influence of heme-binding proteins in heme-catalyzed oxidations. Arch Biochem Biophys 1988, 265(2):539-550. 10.1016/0003-9861(88)90159-2, 3421724.
23. Davies DM, Smith A, Muller-Eberhard U, Morgan WT. Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem Biophys Res Commun 1979, 91(4):1504-1511. 10.1016/0006-291X(79)91235-X, 526319.
24. Chen-Roetling J, Liu W, Regan RF. Hemopexin decreases hemin accumulation and catabolism by neural cells. Neurochem Int 2012, 60(5):488-494. 10.1016/j.neuint.2012.01.024, 3345564, 22342655.
25. Immenschuh S, Nagae Y, Satoh H, Baumann H, Muller-Eberhard U. The rat and human hemopexin genes contain an identical interleukin-6 response element that is not a target of CAAT enhancer-binding protein isoforms. J Biol Chem 1994, 269(17):12654-12661.
26. Immenschuh S, Song DX, Satoh H, Muller-Eberhard U. The type II hemopexin interleukin-6 response element predominates the transcriptional regulation of the hemopexin acute phase responsiveness. Biochem Biophys Res Commun 1995, 207(1):202-208. 10.1006/bbrc.1995.1173, 7857266.
27. Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66(3):232-245. 10.1016/j.surneu.2005.12.028, 16935624.
28. Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW. Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant 2004, 9(1):84-87.
29. Eskew JD, Vanacore RM, Sung L, Morales PJ, Smith A. Cellular protection mechanisms against extracellular heme. heme-hemopexin, but not free heme, activates the N-terminal c-jun kinase. J Biol Chem 1999, 274(2):638-648. 10.1074/jbc.274.2.638, 9872997.
30. Schuller E, Delasnerie N, Moreno P, Tompe L. Electro-immunodiffusion of the proteins of the cerebrospinal fluid: determination of 1 -lipoprotein, 1 -E(C'4) and 2 -glycoprotein I. Clin Chim Acta 1972, 39(1):233-238. 10.1016/0009-8981(72)90321-X, 4338949.
31. Schuller E, Allinquant B, Garcia M, Lefevre M, Moreno P, Tompe L. Electro-immunodiffusion of cerebrospinal fluid proteins. Determination of 2 -HS, ceruloplasmin, - 1A - 1C , hemopexin and IgA. Clin Chim Acta 1971, 33(1):5-11. 10.1016/0009-8981(71)90242-7, 4106481.